Akshay S. Desai

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan et al. · New England Journal of Medicine · 2024 · 709 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Carolyn Y. Ho, Sharlene M. Day, Anna Axelsson Raja et al. · Nature Medicine · 2021 · 132 citations · Full text

Medicine, Cardiology, Pharmacology +5

Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes

Muthiah Vaduganathan, Gerasimos Filippatos, Brian Claggett et al. · Nature Medicine · 2024 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

George L. Bakris, Manish Saxena, Anil Gupta et al. · JAMA · 2024 · 116 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial

Muthiah Vaduganathan, Brian Claggett, Carolyn S.P. Lam et al. · European Journal of Heart Failure · 2024 · 80 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12